Searched for
MANKIND PHARMA IPO RESPONSE
NSE IPO: How India's biggest stock exchange makes money beyond trading fees- Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discoveryMankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...
- Advit Jewels share price slides 5% after strong 37% market debut. Should you buy, sell or hold?Advit Jewels shares made a strong stock market debut, listing at a 37% premium to the IPO price before trimming gains. While analysts remai...
- Explained: Oyo’s long journey to an IPO, from 2021 to 2026Oyo's parent company, PRISM, has filed for a ₹6,650 crore IPO, marking its third attempt to go public after previous delays and withdrawals...
- Advit Jewels shares list at 37% premium over IPO price on NSE, BSEAdvit Jewels shares made a blockbuster stock market debut on Wednesday, listing at up to a 36% premium over the IPO price after the issue w...
- Anthropic unveils 'Claude Science' AI platform for scientific researchThe launch is part of Anthropic's life sciences and healthcare initiative, which the IPO-bound company has been developing since October ...
- 6 IPOs open for subscription with GMPs up to 28%. Check all detailsThe fresh offerings come amid mixed investor interest in the SME segment, although listing performance has remained muted in recent weeks, ...
- Aastha Spintex IPO Day 2: GMP signals 4% listing gain; subscription nears full. Should you apply?Aastha Spintex's Rs 170 crore IPO entered Day 2 with a 4% grey market premium (GMP), indicating a potential listing around Rs 141 versus th...
- Oyo parent Prism files updated IPO papers for fresh issue worth Rs 6,650 croreOYO parent Prism, formerly Oravel Stays, has filed an updated DRHP with SEBI for a Rs 6,650 crore IPO entirely through fresh issue. Proceed...
- The world's most remote inhabited island has an asthma mystery; scientists traced it to just two settlers who arrived in 1817A remote island, Tristan da Cunha, has become a vital natural laboratory for asthma research. Due to its isolated population descended from...
- Aastha Spintex IPO off to a steady start; issue subscribed 52% on Day 1. Check GMP & key detailsAastha Spintex IPO saw a steady start on Day 1, subscribed 52% by mid-session, with strong NII demand leading the response. The issue carri...
- Drone startup Elroy Air to list on Nasdaq via $1 billion SPAC dealCargo drone startup Elroy Air is set to go public in the US through a $1 billion merger with blank-check firm Columbus Circle Capital Corp ...
- IPO wave ahead: Jio, NSE among 10 public offers to watch in rest of 2026India’s IPO market is set for a strong rebound in the second half of 2026, with major listings such as Jio Platforms, NSE and SBI Mutual Fu...
- Over 200x subscription! Advit Jewels becomes the hottest IPO of 2026; GMP at 41%Advit Jewels’ IPO closed with a blockbuster 212.62 times subscription, making it the most sought-after issue of 2026 so far. Strong demand ...
- Advit Jewels IPO Day 3: Issue subscribed 213x on strong retail, NII demand; GMP hints at 40% listing gainsJaipur's Advit Jewels IPO is witnessing overwhelming investor interest, subscribed over 212 times by day three, with a significant 40% grey...
- CSM Technologies IPO Day 2 update: Subscribed 32%, GMP at 4%. Should you subscribe?CSM Technologies' IPO is seeing a subdued response on its second day, with only 32% subscription. Retail investors show more interest, subs...
- Advit Jewels IPO Day 2: Issue subscribed over 20x, GMP signals 41% listing gains. Should you bid?Jaipur-based Advit Jewels' IPO is seeing massive investor interest, subscribed over 20 times on day two with a strong grey market premium. ...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- India's defence export boom could hit ₹65,000 crore by 2030; pvt sector startups the real play: Sunil SubramaniamIndia's defence exports are poised to surpass government targets, reaching ₹60,000-65,000 crore by 2030, according to market expert Sunil S...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
Load More
